Non-Randomized Confirmatory Trial of Laparoscopy-Assisted Total Gastrectomy and Proximal Gastrectomy with Nodal Dissection for Clinical Stage I Gastric Cancer: Japan Clinical Oncology Group Study JCOG1401

´ëÇÑÀ§¾ÏÇÐȸÁö 2016³â 16±Ç 2È£ p.93 ~ p.97

(Kozo Kataoka) - National Cancer Center JCOG Data Center/Operations Office
(Hitoshi Kata) - National Cancer Center Hospital Division Gastric Surgery
(Junki Mizusawa) - National Cancer Center JCOG Data Center/Operations Office
(Hiroshi Katayama) - National Cancer Center JCOG Data Center/Operations Office
(Kenichi Nakamura) - National Cancer Center JCOG Data Center/Operations Office
(Shinji Morita) - National Cancer Center Hospital Division Gastric Surgery
(Takaki Yoshikawa) - Kanagawa Cancer Center Department of Gastrointestinal Surgery
(Seiji Ito) - Aichi Cancer Center Hospital Department of Gastroenterological Surgery
(Takahiro Kinoshita) - National Cancer Center Hospital Division Gastric Surgery
(Takeo Fukagawa) - National Cancer Center Hospital Division Gastric Surgery
(Mitsuru Sasako) - Hyogo College of Medicine Department of Surgery

Abstract

Several prospective studies on laparoscopy-assisted distal gastrectomy for early gastric cancer have been initiated, but no prospective study evaluating laparoscopy-assisted total gastrectomy or laparoscopy-assisted proximal gastrectomy has been completed to date. A non-randomized confirmatory trial was commenced in April 2015 to evaluate the safety of laparoscopy-assisted total gastrectomy and laparoscopy-assisted proximal gastrectomy for clinical stage I gastric cancer. A total of 245 patients will be accrued from 42 Japanese institutions over 3 years. The primary endpoint is the proportion of patients with anastomotic leakage. The secondary endpoints are overall survival, relapse-free survival, proportion of patients with completed laparoscopy-assisted total gastrectomy or laparoscopy-assist-ed proximal gastrectomy, proportion of patients with conversion to open surgery, adverse events, and short-term clinical outcomes. The UMIN Clinical Trials Registry number is UMIN000017155.

Å°¿öµå

Laparoscopy, Gastrectomy, Nonrandomized clinical trial
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
The results of the study protocol will be overall survival, relapse-free survival, proportion of patients with completed laparoscopy-assisted total gastrectomy or laparoscopy-assist-ed proximal gastrectomy, proportion of patients with conversion to open surgery, adverse events, and short-term clinical outcomes.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå